Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community-Acquired Pneumonia in Nursing-Home Residents in the Post-HCAP Era.

Chest·2026

Same author

Human Metapneumovirus: An Underestimated Cause of Severe Respiratory Infection.

Annals of the American Thoracic Society·2026

Same author

Hepatic Venous Pressure Gradient, Noninvasive Tests, and Prognosis Across the Subtypes of Advanced Steatotic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same author

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026

Same author

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

The Lancet regional health. Europe·2026

Same author

Can better oral care reduce non-ventilator hospital-acquired pneumonia?

The Lancet. Infectious diseases·2026

Search research articles

Related Experiment Video

Updated: May 29, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

Advocacy in Pneumonia.

Catia Cilloniz¹, Juan M Pericàs², Alejandro Videla³

¹August Pi i Sunyer Biomedical Research Institute-IDIBAPS, Barcelona 08036, Spain; Faculty of Health Sciences, Continental University, Huancayo 12000, Peru; Ciber de Enfermedades Respiratorias (CIBERES), Barcelona 08036, Spain.

Clinics in Chest Medicine

|May 27, 2026

Summary

This summary is machine-generated.

Pneumonia is a leading infectious cause of death globally, especially in young children and older adults. Increased advocacy, investment, and research are crucial for preventing and treating this neglected yet preventable disease.

Keywords:

Advocacy Awareness Community-acquired pneumonia Infection Pneumonia

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Global Health
Infectious Diseases
Public Health

Background:

Pneumonia is the primary cause of infectious mortality worldwide.
It disproportionately affects children under 5 and older adults.
Despite its impact, pneumonia is a neglected disease requiring greater attention.

Purpose of the Study:

To highlight the critical need for pneumonia advocacy.
To address gaps in effective pneumonia prevention strategies.
To emphasize the importance of public education on this preventable condition.

Main Methods:

Review of current global health challenges posed by pneumonia.
Analysis of existing gaps in pneumonia prevention promotion.
Identification of priority measures for disease control.

Main Results:

Pneumonia advocacy is essential for public awareness and education.
Increased investment in prevention, diagnosis, and treatment is necessary.
Further research is needed on disease impact, etiology, and antimicrobial resistance.

Conclusions:

Pneumonia requires urgent global health prioritization.
Comprehensive strategies involving awareness, investment, and research are vital.
Addressing pneumonia effectively can reduce infectious mortality significantly.